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Adipose tissue is widely recognized as an extremely active endocrine organ producing
adipokines as leptin that bridge metabolism and the immune system. Pre-B-cell
leukemia homeobox (Pbx)-regulating protein-1 (PREP1) is a ubiquitous homeodomain
transcription factor involved in the adipogenic differentiation and insulin-sensitivity
processes. Leptin, as pleiotropic adipokine, and TGF-β, known to be expressed by
primary pre-adipocytes [adipose-derived stem cells (ASCs)] and mature differentiated
adipocytes, modulate inflammatory responses. We aimed to assess for the first
time if leptin and TGF-β interfere with PREP1 expression in both ASCs and mature
differentiated adipocytes. Human ASCs were isolated from subcutaneous adipose
liposuction and, after expansion, fully differentiated to mature adipocytes. In both
ASCs and adipocytes, leptin and TGF-β1 significantly decreased the expression of
PREP1, alone and following concurrent Toll-like receptor 4 (TLR4) activation. Moreover,
in adipocytes, but not in ASCs, leptin increased TLR4 and IL-33 expression, whereas
TGF-β1 enhanced TLR4 and IL-6 expression. Taken together, we provide evidence for
a direct regulation of PREP1 by leptin and TGF-β1 in ASCs and mature adipocytes. The
effects of leptin and TGF-β1 on immune receptors and cytokines, however, are limited
to mature adipocytes, suggesting that modulating immune responses depends on the
differentiation of ASCs. Further studies are needed to fully understand the regulation of
PREP1 expression and its potential for the development of new therapeutic approaches
in obesity-related diseases.
Keywords: adipose tissue, adipocytes, adipocyte-derived stem cells, leptin, PREP1, TLR4, immune system, TGF-
beta1
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INTRODUCTION
Until 25 years ago, white adipose tissue (WAT) was considered
an energetic storage tissue only. Many years of experimental
and clinical research have provided evidence for the crucial
role of WAT in regulating, besides metabolism, the immune
system (Cinti, 2019; Cox et al., 2019). WAT does not only
produce cytokine-like hormones (adipokines), it also hosts a
wide array of resident and infiltrating immune cells, namely, T
and B lymphocytes, macrophages, neutrophils, and eosinophils,
that maintain tissue homeostasis in lean subjects (Huh et al.,
2014). Subcutaneous (peripheral) and visceral (central) WATs
have been proven to serve as an accessible and abundant
source of adipose-derived stem cells (ASCs), which provides
the possibility to apply tissue engineering techniques. For
instance, ASCs, as pluripotent stem cells, can be differentiated
not only into multi-lineage mesodermal cell types (adipocytes,
myocytes, chondrocytes, and osteoblasts) but also into cells
of endodermal and ectodermal origins (Bunnell et al., 2008;
Tobita et al., 2011; Cawthorn et al., 2012). Taking into account
these characteristics, ASCs represent a good in vitro model to
investigate physiological and pathological mechanisms in WAT.
Adipokines, with inflammatory and anti-inflammatory activities,
are known to modulate the immune system. Particularly, IL-6,
IL-33, and leptin participate in the maintenance of the metabolic
balance by increasing the insulin sensitivity and preserving
adipose tissue homeostasis (Rana et al., 2019; Xu et al., 2019).
Leptin is one of the most relevant adipokines that regulates the
crosstalk between adipocytes and the immune system (Bruno
et al., 2005b; Conus et al., 2005; Francisco et al., 2018). Leptin
receptors are widely expressed in cells of the innate and adaptive
immune systems, regulating the inflammatory response in several
diseases (Pérez-Pérez et al., 2017).
Interestingly, there is evidence that leptin can induce the
perpetuation of inflammation by maintaining immune cell
survival (Bruno et al., 2005b; Conus et al., 2005); on the
other hand, leptin can protect bronchial and nasal epithelial
cells (Bruno et al., 2005a, 2009, 2014, 2019), maintaining
and/or restoring epithelial homeostasis. IL-6 and IL-33 are
cytokines induced by Toll-like receptor 4 (TLR4) activation that
play a key role in the development of immune inflammatory
responses in several organs, such as the lung (Hochdörfer
et al., 2011; Martínez-González et al., 2013; Zhao et al., 2021).
Moreover, both IL-6 and IL-33 are involved in anti-inflammatory
immune process and in several physiological systems, such as
skeletal muscle for IL-6: release of IL-6 increased from skeletal
muscle after prolonged exercise is known to be associated with
stimulation of hypertrophic muscle growth and myogenesis
of muscle stem cells in human ASCs (Serrano et al., 2008;
Muñoz-Cánoves et al., 2013; Seo et al., 2018). On the other
hand, IL-33 maintains type 2 innate lymphoid cells (ILC2)
and reduces the risk of metabolic syndrome (Brestoff et al.,
2015). IL-33 is able to counter excessive inflammation in
adipose tissue responses by targeting immune cells expressing
the receptor suppression of tumorigenicity 2 receptor (ST2)
for IL-33. Furthermore, mice lacking ST2 or IL-33 develop
increased adiposity and worsened metabolic profiles, as well
as IL-33 treatment triggers the expansion of a group of
Fox3 + ST2 + Tregs and attenuates adipose tissue inflammation
(Bantulà et al., 2021). Moreover, the metabolic activity of
the epicardial adipose tissue is associated with elevated IL-33
(Gruzdeva et al., 2018).
Leptin and IL-33 are both involved in basophil degranulation
(Koketsu et al., 2013), whereas IL-33 upregulates leptin receptor
at both the mRNA and surface protein levels in human basophils,
indicating that leptin may be a key molecule mediating the
effects of adipocytes on inflammatory cells, such as basophils, by
binding to leptin receptor and activating the cellular functions
(Suzukawa et al., 2011).
It is well known that adipose tissue is an endocrine organ,
but also an immune organ, as it is physiologically infiltrated
by innate immune cells. The health and homeostasis of adipose
tissue is important to contribute for maintaining a regular
and physiological immune response. Adipose tissue exhibits
important roles in regulating energy metabolism and insulin
sensitivity (Huang and Xu, 2021). Nevertheless, when obesity is
present, the low-grade state of inflammation in both omental
and subcutaneous adipose tissues often results in impaired
glucose metabolism and may contribute to the development of
insulin resistance and weight gain. Moreover, obesity and insulin
resistance further compromise the already impaired immune
systems (Andrade et al., 2021).
Both leptin and insulin are of equal importance in the
pathophysiology of obesity and type 2 diabetes (T2DM; Rehman
et al., 2018). On the other hand, leptin and insulin can also
increase the secretion of pro-inflammatory cytokines by immune
cells (Zakharova et al., 2019; Frasca et al., 2020).
Pre-B-cell leukemia homeobox (Pbx)-regulating protein-1
(PREP1) plays a role in metabolic disorders. It is a homeodomain
transcription factor from the three-amino acid loop extension
(TALE) superclass of proteins that dimerizes with Pbx1, which
is implicated in modulating embryonic development (Berthelsen
et al., 1998) and metabolism (Cimmino et al., 2019). Several
studies performed in mice report that PREP1 is involved in
glucose and lipid metabolism regulation of the muscle, liver,
and fat cells, suggesting that PREP1 may provide an early
contribution to obesity and T2DM pathogenesis (Ciccarelli
et al., 2016; Oriente et al., 2018). Moreover, PREP1 deficiency
induces protection from diabetes (Oriente et al., 2008), reduces
inflammatory responses, and increases insulin sensitivity in
adipose tissue (Liotti et al., 2018). The relatively high efficiency
of ASCs in pluripotency can be explained, at least partially, by
their high expression of TGF-β (Sugii et al., 2010), which is
known to regulate differentiation and remodeling. Furthermore,
a recent study investigating the expression of angiogenic markers
during the osteogenesis of ASCs reported an increased expression
of regulatory genes, such as JUN, FOS, and MAPK3, involving
TGF-β pathways (Shaik et al., 2019). Moreover, TGF-β takes part
in obesity-associated inflammation and in T2DM mechanism
(Frühbeck et al., 2020; Zhang et al., 2020), as well as in cancer
together with PREP1 (Risolino et al., 2014). Cytokine production
from ILC2 is controlled also by TGF-β that inhibits adipogenesis
and maintains insulin sensitivity in adipocytes (Lumeng et al.,
2007; Tsurutani et al., 2011).
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However, the precise mechanisms whereby adipocyte
and various immune cells crosstalk with each other to
aggravate obesity-induced adipose inflammation and metabolic
dysregulation remain poorly defined. The present study was
performed to establish the role of leptin and TGF-β in the
regulation of PREP1 expression in both primary human
ASCs and mature differentiated adipocytes. The expression
of additional molecules involved in the interaction with the
immune system was also investigated.
MATERIALS AND METHODS
Reagents
Collagenase A (from Clostridium histolyticum cat no.
11088793001) was from Roche (Indianapolis, IN, United States).
Recombinant human insulin (cat no. 26360.01) and
dexamethasone (cat no. 18660.01) were from Serva (Heidelberg,
Germany).1 Indomethacin (cat no. 70270) was from Cayman
(Ann Arbor, MI, United States). Recombinant human leptin
(398-LP) and recombinant human TGF-β1 (240-B) were
purchased from R&D System (Minneapolis, MN, United States).
Monoclonal PREP1 (B-2): sc-25282 antibody, rabbit polyclonal
TLR4 (H-80): sc-10741 antibody, HBD2 (FL-64): sc-20798
antibody, and goat polyclonal anti-leptin receptor (Ob-R M-18):
sc-1834 antibody were from Santa Cruz Biotechnology, Inc.
(Dallas, TX, United States). Monoclonal CD284 (TLR4) PE (cat
no 12-9917) antibody was from eBioscience (San Diego, CA,
United States). Monoclonal anti-CD34, anti-CD45, anti-CD73,
anti-CD90, and anti-CD105 antibodies, pure or FITC/PE
conjugate, were purchased from MACS, Miltenyi Biotec
(Germany). Normal donkey (NDS, 017-000-121), normal goat
serum (NGS, 005-000-121), and TRITC-conjugated donkey anti-
rabbit IgG (711-025-152) were from Jackson Immunoresearch
(West Grove, PA, United States). Alexa Fluor R© 488-conjugated
goat anti-mouse IgG (A 11029) was from Thermo Fisher
Scientific (Waltham, MA, United States). TRIzol reagent
was from Life Technologies (Carlsbad, CA, United States),
iScript cDNA Synthesis kit was from BioRad (Hercules, CA,
United States), and FAM-labeled probe and primers were from
Applied Biosystems (Foster City, CA, United States).
Liposuction Procedure, Isolation of ASCs
From Adipose Tissue, and Cell Culture
Adipose tissue was collected by liposuction aspiration of
subcutaneous fat from non-obese and non-diabetic anonymous
subjects [n = 7; 5 females; mean age, 39; mean body
mass index (BMI), 29]. All subjects were non-smokers and
without hypertension, cardiovascular or metabolic disease,
cancer, or chronic pulmonary diseases. They signed their
informed consensus, and the Ethics Committee of Policlinico,
Giaccone Hospital, Palermo, Italy (authorization reference
number 12/2014) in agreement with the Helsinki Declaration
approved the study. Every adipose sample was kept at room
temperature (RT) for less than 24 h prior to use, and
1www.serva.de
ASCs were isolated as previously described (Bunnell et al.,
2008). Briefly, approximately 500 mL liposuction aspiration was
washed extensively in a sterile bottle to remove contaminating
heterogeneous cell population, namely, circulating blood cells,
fibroblasts, pericytes, and endothelial cells, by two subsequent
washing (1 h, RT) in a ratio of 1:1 with phosphate-buffered
saline (PBS) containing 5% penicillin/streptomycin and 10%
fungizone (P/S/F). The stromal vascular fraction was then
separated from the lower layer of heterogeneous cells and
discharged. The sample was shaken for 1 h at 37◦C in PBS
containing 2% P/S, 10% F, and 0.075% collagenase type I and
subsequently neutralized by adding in the ratio 1:1, 5 mL of
D-MEM with 20% heat-inactivated fetal bovine serum (FBS).
After centrifugation at 2,000 rpm for 5 min, the pellet was washed
in lysis buffer and incubated for 10 min on ice and then washed
and incubated in two wells of a 24-well plate at 37◦C with 5%
CO2 in complete proliferation medium: D-MEM cell growth
medium high glucose (4.5 g/L D-glucose), 3.7 g/L NaHCO3,
W/O sodium pyruvate, L-glutamine, and phenol red (ECM0106L;
Euroclone, Milan, Italy) with 1% antibiotics mixture (penicillin,
streptomycin sulfate, and amphotericin B, 03-033-1; Biological
Industries Israel Beit Haemek Ltd., Kibbutz Beit-Haemek, Israel),
1% L-glutamine 200 mM, 1% sodium pyruvate, and 20% FBS.
The yield of ASCs (undifferentiated pre-adipocytes) obtained
from liposuction sample after digestion was patient-dependent.
Usually, we obtained approximately 2 × 105 cells in a single
well of a 12-well plate or approximately 1 × 105 cells in a
single well of a 24-well plate for an amount of approximately
500 or 250 mg of liposuction aspiration fluid adipose tissue,
respectively. Seventy-two hours after plating, D-MEM cell growth
medium 20% FBS was replaced with fresh D-MEM cell growth
medium 10% FBS. This latter was changed every 3 days. At
this point, there were two options: ASCs were allowed to reach
between 80 and 90% confluence and induced to differentiate;
otherwise, ASCs were directly stimulated as briefly described:
ASCs were cultured in D-MEM cell growth medium 10% FBS in
the presence and absence of recombinant human leptin (0.001–
2.5 µM) and recombinant human TGF-β1 (40–1.600 pM) for
24 h. The best active concentrations were 0.5 µM for leptin and
400 pM for TGF-β1. For the TLR4 pathway activation, we used
endotoxin, LPS (purchased from Sigma-Aldrich, St. Louis, MO,
United States; 10 µg/mL) for 24 h. Cells and supernatants (stored
at –80◦C after centrifugation until ELISA test) were then collected
for further analyses.
Adipogenic Differentiation
Adipose-derived stem cells display multipotent characteristics,
meaning that despite they derive from an adult human tissue,
they maintain the ability to differentiate into multilineage
cell types (adipogenic, osteogenic, chondrogenic, and neuronal
differentiation) (Bunnell et al., 2008), leading to their interest
for their potential therapeutic value in the regenerative medicine
field. We differentiated ASCs only in mature adipocytes. Specific
differentiation in mature adipocytes was directly induced by
adding the D-MEM differentiation medium: it means that
D-MEM cell growth medium 20% FBS was enriched with
1 µM dexamethasone, 1 µM insulin, and 50 µM indomethacin.
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FIGURE 1 | (A) Isolation from liposuction sample. (B) Upper and lower left, ASCs and mature differentiated adipocytes, both stained with red oil (×100): upper left
figure shows ASCs stained, negative for red oil test, and adherent in plasticware plate; lower left shows mature differentiated adipocytes stained, positive for red oil
test, and adherent in plasticware plate. (B) Upper and lower right, differential interference contrast (DIC-Nomarski) combined with DAPI (×400) for ASCs and mature
differentiated adipocytes is shown. (C) Mature differentiated adipocytes with red oil staining (magnification at ×100, ×200, ×400, and ×630, scale bar = 40 µm) are
shown. Axioskop-2-Zeiss microscope.
When 1 × 105 ASCs per well seeded in a 24-well plate were
at 80–90% confluence, we started to induce the adipogenic
differentiation by adding 1 mL complete D-MEM differentiation
medium. The medium was carefully changed twice per week.
In 28 days, the cell differentiation process was completed.
At this day, mature adipocytes either were tested for red
oil staining (below described) or were cultured in complete
D-MEM differentiation medium, in the presence and absence
of recombinant human leptin and recombinant human TGF-β1
at the same conditions used for ASCs. Cells and supernatants
(stored at –80◦C after centrifugation until ELISA test) were then
collected for further analyses.
Red Oil Staining
The accumulation of neutral lipids was detected by staining the
cells on a slide as described: cells, adherent in a plasticware
plate, were fixed with 10% paraformaldehyde for 90 min at 37◦C;
afterward, cells were stained in a solution of Oil Red O solution
(Oil Red O solution—0.5% in isopropanol (O1391) from Sigma-
Aldrich, St. Louis, MO, United States) for 30 min at 37◦C. The
percentage of cells undergoing adipogenesis was calculated by
image analyzer microscope (Axioskop-2-Zeiss, Jena, Germany).
Flow Cytometer
The multipotent ASCs cell differentiation process from mature
differentiated adipocytes was also assessed by specific flow
cytometric surface antigen expression analyses of both ASCs
and mature differentiated adipocytes. The mesenchymal stromal
cells express CD73, CD90, and CD105 and lack the expression
(≤2% positive) of CD45, CD34, and other surface antigens
(Dominici et al., 2006). Furthermore, ASCs and adipocytes
were stimulated as described above; cells were then fixed with
4% paraformaldehyde, permeabilized with PBS containing 1%
FBS, 0.3% saponin, and 0.1% Na azide, and stained with anti-
human PREP1, TLR4, HBD2, and leptin receptors primary
antibodies and the appropriate PE- and FITC-conjugated
secondary antibodies. Marker expression was evaluated using
a FACSCalibur flow cytometer (Becton Dickinson, Mountain
View, CA, United States). Non-immune IgGs at the same
concentration as the primary antibody were used as negative
controls. Percentages of positive cells were determined from
forward and sideways scatter patterns. Non-specific binding
and background fluorescence were quantified by analyzing the
negative controls.
Immunofluorescence
To maintain the integrity of marker membrane, ASCs were
seeded with proliferation medium on glass coverslips, previously
sterilized with ethanol 70%, and allowed to attach for 72 h
before stimulation or before adding differentiation medium.
After stimulation of both ASCs and adipocytes, cells were fixed
with 4% paraformaldehyde for 15 min, permeabilized with 0.1%
Triton X-100 in PBS for 5 min, and blocked in 0.1% Tween
20 in PBS (TPBS) containing 2% BSA and 3% normal goat
serum for PREP1, CD34, CD73, and CD90 or 3% normal
donkey serum for TLR4, for 1 h, before staining. Cells were
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FIGURE 2 | (A) Flow cytometry analysis on ASCs and on mature differentiated adipocytes for antigen surface markers: the results are shown as box-plots with
medians (lines inside the boxes), mature differentiated adipocytes significantly expressed CD105, CD73, and CD90 in comparison with ASCs (*p = 0.0272 for
CD105, **p < 0.0001 for CD73, and CD90; n = 3 experiments). Analysis of variance (ANOVA), Fisher’s PLSD. Right, representative examples of flow cytometric
analysis in ASCs and in adipocytes. The numbers indicate the percentage of double positive cells for CD73 and CD90. (B) Representative immunofluorescence for
antigen surface markers on mature differentiated adipocytes is shown: higher, differential interference contrast (DIC-Nomarski) combined with DAPI and fluorescence;
lower, DAPI with fluorescence; negative, CD34 (green), CD73 (red), and CD90 (green) (magnification at ×400, scale bar = 40 µm). Axioskop-2-Zeiss microscope.
then incubated with anti-PREP1, anti-CD34, anti-CD73, anti-
CD90, and anti-TLR4 (all, 1:50) antibodies in TPBS containing
2% BSA and 1.5% normal goat or 1.5% normal donkey serum,
respectively, for 2 h at RT. Incubation with the appropriate
secondary antibodies Alexa Fluor 488 or TRITC-conjugated
(1:200) in TPBS containing 2% BSA and 1.5% normal goat or
1.5% normal donkey serum, respectively, was performed for
30 min. Glass coverslips were mounted on slides in Vectashield
(Vector Laboratories, Burlingame, CA, United States) with 406-
diamidine-2-phenylindole-dihydrochloride (DAPI) to visualize
the nuclei. Staining of the samples was observed and evaluated
with an Axioskop-2-Zeiss microscope/software. Control slides
were prepared using an irrelevant antibody of the same isotype
and at the same concentration as the specific primary, and no




The whole RNA was isolated from ASCs and from mature
adipocytes using TRIzol reagent (Life Technologies) following
the manufacturer’s instruction. Then, 1 µg of RNA was reverse-
transcribed to cDNA, using iScript cDNA Synthesis kit (BioRad).
Quantitative real-time PCR by TaqMan Assay to evaluate the gene
expression of PREP1, leptin, leptin receptors, TGF-β1, TLR4,
IL-6, and IL-33 was performed. Transcripts were carried out
with StepOnePlus Real-time PCR System (Applied Biosystems,
Foster City, CA, United States) using specific FAM-labeled
probe and primers (pre-validated TaqMan Gene expression assay
for PREP1, Hs00231814_m1, for leptin, Hs00174877-m1, for
leptin receptors, Hs00174492-m1, for TGF-β1, Hs00998133-m1,
for TLR4, Hs00152939-m1, for IL-6, Hs00985639-m1, and for
IL-33, Hs01125943-m1; Applied Biosystems). Gene expression
was normalized to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (pre-validated TaqMan Gene expression assay for
GAPDH, Hs03929097g1; Applied Biosystems) in each case
(Haslett et al., 2002). The results were obtained with the
comparative Ct method (2−11Ct), and untreated cells were used
as reference samples.
Cytokines Release by ASCs and Mature
Differentiated Adipocytes
Supernatants were recovered, centrifuged, and stored at –80◦C
until assayed. IL-6, IL-8, IL-33, IL-1β, and TNF-α were measured
with a commercially available ELISA Kit (Duo Set ELISA;
R&D Systems, Minneapolis, MN, United States) following the
manufacturer’s instructions.
Statistical Analysis
The analysis of results was performed from 3 to 7 independent
biological replicates. The numbers of independent experiments
are indicated in the figure legends. Analysis of variance (ANOVA)
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FIGURE 3 | (A) Flow cytometry analysis on ASCs for PREP1: both leptin (0.05 µM) and TGF-β1 (400 nM) significantly reduced PREP1 expression (*p = 0.0149 and
**p = 0.0318, respectively); the results are shown as box-plots with medians (lines inside the boxes), 25th and 75th percentiles (limits of boxes), and the 10th and
90th percentiles (whiskers) (n = 7 experiments). Analysis of variance (ANOVA), Fisher’s PLSD. Right, representative examples of flow cytometric analysis. The
numbers indicate the percentage of positive cells for PREP1. (B) Representative immunofluorescence for PREP1 (green) on ASCs is shown: higher, differential
interference contrast (DIC-Nomarski) combined with DAPI and fluorescence; lower, DAPI with fluorescence (magnification at ×400, scale bar = 40 µm).
Axioskop-2-Zeiss microscope.
was used for testing differences between means. The possible
association between categorical variables was evaluated by the
accurate Fisher’s exact test. A p-value < 0.05 was considered
statistically significant.
RESULTS
Characterization of ASCs and
Differentiated Adipocytes
After the isolation from the liposuction sample (different
devices), the undifferentiated multipotent ASCs were cultured
and expanded by using specific proliferation culture medium
(Figure 1A). ASCs were adherent to the plasticware surface
(Figure 1B, upper left), as one of the three minimal criteria
required by the Mesenchymal and Tissue Stem Cell Committee
of the International Society for Cellular Therapy (Dominici et al.,
2006). The other two criteria are the specific surface antigen (Ag)
expression and the multipotent differentiation potential. The
undifferentiated multipotent ASCs were expanded, and parts of
them were fully differentiated into mature adipocytes (Figure 1B,
lower left). We assessed the full differentiation in adipocytes
by red oil staining and specific surface markers. By red oil
staining, we observed the characteristic red neutral lipid droplets
in fully mature differentiated adipocytes (Figures 1B, lower left,
C). In contrast, the undifferentiated pre-adipocytes were red
oil negative (Figure 1B, upper left). By flow cytometry and
immunofluorescence, we observed an increased expression of
CD73, CD90, and CD105 in differentiated adipocytes compared
with ASCs (p < 0.0001, p < 0.0001, p = 0.0243, respectively),
whereas the expression of CD34 and CD45 markers was not
significantly different between the two cytotypes and less than
2% (Figure 2). Figure 2B shows the DIC-Nomarski overlay
with fluorescence to appreciate the morphology of both the
pre-adipocytes and adipocytes.
Leptin and TGF-β1 Decrease PREP1
Levels but Increase TLR4 Surface
Expression
By flow cytometry and immunofluorescence, we observed that
both leptin and TGF-β1 significantly reduced PREP1 expression
(∗p = 0.0149 and ∗∗p = 0.0318, respectively) in both ASCs
(Figure 3) and mature differentiated adipocytes (∗p = 0.0138
and ∗∗p = 0.0461, respectively) (Figure 4). Furthermore, as
TLR4 has been implicated in adipose tissue inflammation, the
effects of both leptin and TGF-β1 on TLR4 expression were
evaluated. Both leptin and TGF-β1 significantly increased TLR4
expression (∗p = 0.0178 and ∗∗p = 0.0325, respectively) in mature
differentiated adipocytes (Figure 5), but not in ASCs. To test the
possible role of TLR4 in PREP1 regulation, the effect of LPS, the
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FIGURE 4 | (A) Flow cytometry analysis on mature differentiated adipocytes for PREP1: both leptin (0.05 µM) and TGF-β1 (400 nM) significantly reduced PREP1
expression (*p = 0.0138 and **p = 0.0461, respectively); the results are shown as box-plots with medians (lines inside the boxes), 25th and 75th percentiles (limits of
boxes), and the 10th and 90th percentiles (whiskers) (n = 6 experiments). Analysis of variance (ANOVA), Fisher’s PLSD. Right, representative examples of flow
cytometric analysis. The numbers indicate the percentage of positive cells for PREP1. (B) Representative immunofluorescence for PREP1 (green) on mature
differentiated adipocytes is shown: higher, differential interference contrast (DIC-Nomarski) combined with DAPI and fluorescence; lower, DAPI with fluorescence
(magnification at ×400, scale bar = 40 µm). Axioskop-2-Zeiss microscope.
main agonist of TLR4, also in combination with leptin or TGF-
β1, on the expression of PREP1 in both ASCs and adipocytes was
assessed by flow cytometry. In ASCs, LPS only when combined
with leptin or TGF-β1 versus medium significantly reduced
PREP1 expression (p = 0.0135 and p = 0.0100, respectively)
(Figure 6A). In adipocytes, both LPS alone versus medium
and combined with leptin or TGF-β1 significantly reduced
PREP1 expression (p = 0.0136, p = 0.0484, and p = 0.0319,
respectively) (Figure 6B).
Leptin and TGF-β1 Act Independently in
ASCs and Mature Adipocytes
Previous studies have shown that the expression of leptin and
TGF-β1 is inversely correlated in airway remodeling processes
in asthma and allergic rhinitis (Bruno et al., 2009, 2014). It
has been previously demonstrated that TGF-β1 reduces leptin
receptor expression in bronchial epithelial cells, and that leptin
reduces TGF-β1 release in vitro (Christensen et al., 2018).
Here, we investigated whether both leptin and TGF-β1 affected
leptin receptor/leptin expression, and whether, conversely, leptin
affected TGF-β1 mRNA expression in ASCs and mature
adipocytes. We did not observe similar findings as previously
described in bronchial epithelial cells (Figures 7A,B, 8A,B),
supporting the concept that leptin and TGF-β1 act independently
in ASCs and adipocytes.
IL-6 Gene Expression and Protein
Release Are Increased by TGF-β1 but
Not by Leptin
As we wanted to gain insight on the role of leptin and
TGF-β1 in modulating inflammatory responses by both ASCs
and adipocytes, the effects of both leptin and TGF-β1 were
explored assessing the releases of antimicrobial peptide beta-
defensin 2 (HBD2) protein and multiple cytokines, namely,
TNF-α, IL-1β, IL-6, IL-8, and IL-33. HBD2 protein expression
was not significantly affected by either leptin or TGF-β1,
on both ASCs and adipocytes (Figures 7A, 8A). In mature
differentiated adipocytes, IL-6 gene expression was significantly
increased by TGF-β1 versus medium and leptin (p = 0.0203
and p = 0.0179, respectively) (Figure 8B), whereas PREP1
gene expression was significantly increased by TGF-β1 versus
medium and leptin (p = 0.0008 and p = 0.0022, respectively)
(Figure 8B). Moreover, in mature differentiated adipocytes, IL-
6 protein release was significantly increased by TGF-β1 only
but not leptin (Figure 8C). On the other hand, IL-33 protein
release was significantly increased by leptin and not TGF-β1
(Figure 8C), but IL-33 mRNA expression was not significantly
different. In ASCs, both IL-33 mRNA and protein were not
detectable. Moreover, TNF-α and IL-1β were neither detectable
in ASCs nor in adipocytes. Finally, the expression of IL-8 was
not significantly different following leptin or TGF-β1 stimulation
(Figures 7C, 8C).
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FIGURE 5 | (A) Flow cytometry analysis on mature differentiated adipocytes for TLR4: both leptin (0.05 µM) and TGF-β1 (400 nM) significantly increased TLR4
expression (*p = 0.0178 and **p = 0.0325, respectively); the results are shown as box-plots with medians (lines inside the boxes) (n = 4 experiments). Analysis of
variance (ANOVA), Fisher’s PLSD. Right, representative examples of flow cytometric analysis. The numbers indicate the percentage of positive cells for TLR4.
(B) Representative immunofluorescence for TLR4 (red) on mature differentiated adipocytes is shown: higher, differential interference contrast (DIC-Nomarski)
combined with DAPI and fluorescence; lower, DAPI with fluorescence (magnification at ×400, scale bar = 40 µm). Axioskop-2-Zeiss microscope.
DISCUSSION
Although pluripotent ASCs clearly hold immense therapeutic
promise and are therefore at the forefront of regenerative
medicine, the developmental relevance of these cells remains
poorly established (Cawthorn et al., 2012). Moreover, ASCs
represent a good in vitro model to investigate the mechanisms
responsible for obesity in humans. Obesity is an epidemic disease
characterized by a chronic low-grade state of inflammation;
obesity and T2DM are both genetically defined and of
absolute concern globally, in almost all countries in the world
(Christensen et al., 2018; Patti et al., 2018; Assaad Khalil et al.,
2019; Boachie et al., 2020). In this study, we investigated
the modulation of PREP1 expression in ASCs and mature
differentiated adipocytes by the cytokines leptin and TGF-β1.
We report the following new findings: (1) leptin and TGF-β1
significantly decrease PREP1 protein expression in both ASCs
and mature adipocytes. (2) TGF-β1 significantly reduces PREP1
mRNA expression in adipocytes. (3) Leptin and TGF-β1 increase
TLR4 expression in mature adipocytes but not in ASCs. (4)
TLR4 activation by LPS decreases PREP1 protein expression in
adipocytes. (5) In mature adipocytes, TGF-β1 increases both IL-6
mRNA and protein release, whereas leptin increases IL-33 release.
Alterations of differentiation, proliferation, and endocrine
function, such as those that occur in conditions of excess
(obesity), deficit (lipodystrophy), and/or altered regional
distribution of adipose tissue, are frequently associated with
insulin resistance frameworks predisposed to T2DM (Capel et al.,
2018). Leptin and insulin are equally important in the metabolic
features of the pathophysiology of obesity (Rehman et al.,
2018), and PREP1 plays a primary role in organogenesis and
metabolism (Cimmino et al., 2019). PREP1 has been identified
as gene encoding for a homeodomain transcription factor, which
plays a relevant activity in glucose and lipid homeostasis (Oriente
et al., 2008). In this regard, it has been observed that hypomorphic
heterozygous mice (PREP1i/+), expressing low levels of PREP1
protein, are protected from streptozotocin-induced diabetes,
exhibit improved insulin sensitivity, and reduce visceral adipose
tissues (Oriente et al., 2013). Increased PREP1 levels lead to
reduced adipocyte differentiation (Liotti et al., 2018).
We demonstrate in this study that leptin, TGF-β1, or TLR4
activation, by decreasing PREP1 levels, can limit the adipogenesis
and, at the same time, may maintain adipose tissue homeostasis.
This latter concept is also important in understanding the
different basal PREP1 expression levels in ASCs compared
with mature differentiated adipocytes. PREP1 is a notable
transcription factor involved in embryogenesis and first organ
development. Its downregulation in zebrafish and its deletion in
mice were associated with embryonic lethality (Fernandez-Diaz
et al., 2010). Based on these concepts, it is conceivable that PREP1
expression is higher (basal PREP1 expression, mean = 38%)
in ASCs than in mature differentiated adipocytes (basal PREP1
Frontiers in Cell and Developmental Biology | www.frontiersin.org 8 July 2021 | Volume 9 | Article 700481
fcell-09-700481 July 7, 2021 Time: 18:35 # 9
Bruno et al. Leptin and TGF-β1 Reduce PREP1
FIGURE 6 | (A) Flow cytometry analysis on ASCs for PREP1 with and without LPS for TLR4 activation: both leptin (0.05 µM) and TGF-β1 (400 nM) significantly
reduced PREP1 expression with or without LPS (10 µg/mL); medium vs. leptin + LPS (p = 0.0135); medium vs. leptin (p = 0.0034); medium vs. TGF-β1 + LPS
(p = 0.0100); medium vs. TGF-β1 (p = 0.0168); the results are shown as box-plots with medians (lines inside the boxes), 25th and 75th percentiles (limits of boxes),
and the 10th and 90th percentiles (whiskers), at least n = 3 experiments. Analysis of variance (ANOVA), Fisher’s PLSD. Right, representative examples of flow
cytometric analysis. The numbers indicate the percentage of positive cells for PREP1. (B) Flow cytometry analysis on mature differentiated adipocytes for PREP1
with and without LPS for TLR4 activation: both leptin (0.05 µM) and TGF-β1 (400 nM) significantly reduced PREP1 expression with or without LPS (10 µg/mL);
medium vs. LPS (p = 0.0136); medium vs. leptin + LPS (p = 0.0484); medium vs. leptin (p = 0.0032); medium vs. TGF-β1 + LPS (p = 0.0319); medium vs. TGF-β1
(p = 0.0116); the results are shown as box-plots with medians (lines inside the boxes), 25th and 75th percentiles (limits of boxes), and the 10th and 90th percentiles
(whiskers), at least n = 3 experiments. Analysis of variance (ANOVA), Fisher’s PLSD. Right, representative examples of flow cytometric analysis. The numbers indicate
the percentage of positive cells for PREP1.
expression, mean = 6%). In this context, a previous study
suggested that IL-33 is produced by M2 macrophages, which
sustain adipose tissue homeostasis.
Interestingly, IL-33 contributes to maintain the lean state
through the activation of anti-inflammatory M2 macrophages,
and in humans, low serum IL-33 levels are associated with high
BMI (Liew et al., 2016; Bantulà et al., 2021).
In contrast, classically activated M1 macrophages produce
IL-1β, TNF-α, and IL-8 (Rana et al., 2019). Furthermore, a
recent study performed in diabetic miceob/ob demonstrated
increased expression of TNF receptor genes, whereas IL-
33, cholecystokinin, plasminogen activator, IL-1β, and
serine peptidase inhibitor genes were downregulated
(Yıldız et al., 2020). In agreement with this study, we observed
that IL-1β and TNF-α are not expressed in normal ASCs and
mature differentiated adipocytes. IL-8 is equally expressed
in both ASCs and adipocytes, whereas leptin alone is able
to significantly increase IL-33 protein release by mature
differentiated adipocytes.
We used ASCs derived from non-obese and non-diabetic
patients, both males and females, with a range of BMI in
overweight. In clinical practice, recombinant leptin is an
important experimental and therapeutic tool: recent studies
on metreleptin (recombinant methionyl human leptin) have
suggested its efficacy in patients with T2DM (Vasandani et al.,
2017) as leptin acts directly on liver cells to reduce the
production of glucose and to increase the sensitivity of insulin
(Rehman et al., 2018).
To date, innovative hypoglycemic therapies have not only
metabolic but also pleiotropic effects, directing the diabetologist
no longer to the evaluation of glycemia but above all in the
“tailored” management of the patient and the complications
of the metabolic syndrome (Patti et al., 2020). The metabolic
obese patient, thanks to the new therapeutic approach that
targets also the immune system and the cellular senescence
as causal factors in obesity-related inflammation, has a new
hope for treating obesity-related metabolic dysfunction and its
complications (Palmer et al., 2019). On the other side, TLR4
pathway dysregulation may also account for obesity-associated
inflammation and insulin resistance (Zhang et al., 2020). In
this regard, both beneficial and detrimental effects of TLR4
pathway activation have been demonstrated on the functionality
of adipose tissue in experimental mouse studies (Tao et al.,
2017). During a chronic high-saturated fat diets challenge, TLR4
supports adipose inflammation that in turn protects insulin
sensitivity through promoting healthy adipose tissue remodeling
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FIGURE 7 | (A) Flow cytometry analysis on ASCs for leptin receptors, TLR4 and HBD2: there are no significant differences among the conditions. (B) n = 3
experiments; quantitative real-time PCR of leptin and its receptors, TGF-β1, PREP1, TLR4, and IL-6 transcripts: there are no significant differences among the
conditions. (C) At least n = 7 experiments; IL-6 and IL-8 release by ASCs: there are no significant differences among the conditions.
and expansion. On the other hand, during an acute challenge with
saturated fatty acids, a negative role of TLR4 as a mediator of
insulin resistance in the adipocytes was observed.
Here, although the direct impact of leptin, TGF-β1, or TLR4
activation (by adding LPS) in the differentiation processes of
ASCs was not assessed, we speculate that leptin, TGF-β1, or
TLR4 activation reduced PREP1, a molecule with a known
fundamental role in the adipocyte differentiation process, can
also reduce adipogenesis. The impaired capacity of omental
compared with subcutaneous adipose tissues for remodeling and
expanding through hyperplasia is thought to be associated with
visceral adiposity with insulin resistance and metabolic health. In
this context, several experimental studies have been performed
to test this hypothesis. In omental adipose tissue, local factors
including inflammatory cytokines and members of the TGF-β
superfamily inhibited adipogenesis and also hormonal factors,
such as glucocorticoids regulate adipogenesis (Lee and Fried,
2014; Almuraikhy et al., 2016). Furthermore, TGF-β receptor
mRNA levels were more robustly induced by low concentrations
of dexamethasone, and ASCs produced higher levels of TGF-
β ligands, which act in an autocrine/paracrine loop to inhibit
adipogenic differentiation (Lee et al., 2019). Our results on PREP1
decreased by TGF-β1 are in line with these previously published
observations and allow us to speculate that the health of WAT
could be maintained by leptin and TGF-β1. Leptin and TGF-β1
are thereby protective cytokines in the context of physiological
adipogenesis and healthy adipose tissue, as they increase TLR4
and decrease PREP1 expression. Our finding that TLR4 activation
in mature adipocytes reduced PREP1 expression further supports
the assumption that activation of the TLR4 pathway has beneficial
metabolic effects. The data obtained in ASCs, showing that TLR4
activation further reduces the expression of PREP1 in cells co-
stimulated with leptin or TGF-β1, are in support of this concept.
Leptin does not seem to induce TLR4 pathway activation as we
observed no increased HBD2 expression or increased IL-8, IL-1β,
TNF-α, and IL-6 expression levels. The lack of increased HBD2
protein expression is consistent with previous observations
reporting that leptin, not alone, but together with other
cytokine, enhances IL-1β-induced HBD2 secretion and mRNA
expression in keratinocytes via the NF-kB pathway in epidermal
keratinocytes (Kanda and Watanabe, 2008). In contrast to leptin,
TGF-β1 can increase IL-6 mRNA expression and IL-6 protein
release, as recently reported in the field of obesity and metabolic
syndrome (Warbrick and Rabkin, 2019). IL-6 is also considered
as a myokine, produced by the skeletal muscle during physical
activity that counteracts the inflammatory adipokines produced
by the adipose tissue of the sedentary subjects (Pedersen and
Febbraio, 2012). Exercise and adipose tissue are associated with
elevated plasma concentrations of IL-6 (Ferrandi et al., 2018),
which counteracts obesity, insulin resistance, and T2DM. The
increase in systemic concentrations of IL-6 is associated with
the adipose tissue being the main source of this cytokine
(Herder et al., 2005). IL-6 exhibits systemic effects on the liver,
adipose tissue, and immune system. IL-6 also mediates the
crosstalk between intestinal L cells and pancreatic islets: high
concentrations of IL-6 in response to exercise stimulate glucagon-
like peptide-1 (GLP-1) secretion from intestinal L cells and from
pancreatic alpha cells, improving insulin secretion and blood
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FIGURE 8 | (A) Flow cytometry analysis on mature differentiated adipocytes for leptin receptors and HBD2: there are no significant differences among the
conditions. (B) n = 3 experiments; quantitative real-time PCR of leptin and its receptors, TGF-β1 and IL-33 transcripts: there are no significant differences among the
conditions; RT-PCR of PREP1 transcripts is significantly reduced only by TGF-β1 (400 nM) versus medium (*p = 0.0008) and versus leptin (0.05 µM) (**p = 0.0022);
RT-PCR of TLR4 transcripts is significantly increased only by leptin (0.05 µM) versus TGF-β1 (400 nM) (*p = 0.0143); RT-PCR of IL-6 transcripts: it is significantly
increased only by TGF-β1 (400 nM) versus medium (*p = 0.0203) and versus leptin (0.05 µM) (**p = 0.0179). (C) At least n = 7 experiments; IL-6, IL-8, and IL-33
release by mature differentiated adipocytes: for IL-8, there are no significant differences among the conditions, whereas IL-6 was significantly increased only by
TGF-β1 (400 nM) versus medium (*p = 0.0486) and versus leptin (0.05 µM) (**p = 0.0199), and IL-33 was significantly increased only by leptin (0.05 µM) versus
medium (*p = 0.0486) and versus TGF-β1 (400 nM) (*p = 0.0424). Analysis of variance (ANOVA), Fisher’s PLSD.
sugar (Pedersen and Febbraio, 2012). In metabolic models, the
beneficial effects of IL-6 were maintained, and the neutralization
of IL-6 resulted in an additional increase in blood sugar and
a decrease in GLP-1 in the pancreas. IL-6 also prevents the
induction of insulin resistance and the deterioration of glucose
homeostasis (Lazar, 2005). IL-6 can adapt the metabolism to
physical exercise and obesity during pro-inflammatory states.
This interaction between insulin sensitive tissues and insulin-
producing cells is mediated by IL-6, which acts on L and alpha
cells to promote the secretion and production of GLP-1.
CONCLUSION AND TAKE-HOME
MESSAGE
The role of leptin and TGF-β1 in reducing PREP1 expression,
with and without activation of TLR4, might be interpreted
as a protective role of a healthy adipose tissue, to prevent
(primary prevention) the switch to an unhealthy adipose
tissue characterized by pathological adipogenesis, insulin
resistance, and infiltrating M1 macrophages producing the
pro-inflammatory adipokines TNF-α and IL-1β. Leptin, TGF-β1,
and TLR4 pathway through PREP1 reduction or increased IL-6
expression could be promising new biological markers and
therapeutic targets in obesity-related diseases.
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